← Back to Respiratory References     ↑ View All References

Anthrax: A Bioterrorist Weapon, 2nd Edition - Suggested Reading And References

Alibek, K., & Handelman, S. (1999). Biohazard. New York, NY: Random House.

Anand, G. (2001). Mayo Clinic, unit of Roche develop rapid anthrax test. Retrieved from http://www.wsj.com/articles/SB10049 79020253243840

Barakat, L. A., Quentzel, H. L., Jernigan, J. A., Kirschke, D. L., Griffith, K., Spear, S. M., … Hadler, J. L. (2002). Fatal inhalational anthrax in a 94-year-old Connecticut woman. Journal of the American Medical Association, 287(7), 863-868.

California Department of Public Health. (2012). Anthrax fact sheet. Retrieved from https://www.cdph.ca.gov/HealthInfo/discond/Documents/Anthrax.pdf

Centers for Disease Control and Prevention. (2007). Emergency preparedness and re-sponse: Bioterrorism overview. Retrieved from http://emergency.cdc.gov/bioterrorism/overview.asp

Centers for Disease Control and Prevention. (2013) Anthrax: Basics. Retrieved from http://www.cdc.gov/anthrax/basics

Centers for Disease Control and Prevention. (2014a). Anthrax: Treatment. Retrieved from http://www.cdc.gov/anthrax/medical-care/treatment.html

Centers for Disease Control and Prevention. (2014b). CDC director releases after-action report on recent anthrax incident; highlights steps to improve laboratory quality and safety. Retrieved from http://www.cdc.gov/media/releases/2014/p0711-lab-safety.html

Centers for Disease Control and Prevention. (2014c). Emergency preparedness and response: Facts about the Laboratory Response Network. Retrieved from http://emergency.cdc.gov/lrn/factsheet.asp

Ebrahimi, C. M., Kern, J. W., Sheen, T. R., Ebrahimi-Fardooee, M., van Sorge, N. M., Schneewind, O., & Doran, K. S. (2009). Penetration of the blood-brain barrier by Bacillus anthracis requires the pXO1 encoded BsIA protein. Journal of Bacteriology, 191(23), 7165-7173.

Grotton, F., & Shea, D. A. (2011). Congressional Research Service: Federal efforts to address the threat of bioterrorism: Selected issues and options for Congress. Retrieved from https://www.fas.org/sgp/crs/terror/R41123.pdf

Guillemin, J. (2006). Scientists and the history of biological weapons: A brief historical overview of the development of biological weapons in the twentieth century. EMBO Reports, 7(Spec No), S45-S49.

Hawley, R. J., & Eitzen, E. M., Jr. (2001). Biological weapons – A primer for microbiologists. Annual Review of Microbiology, 55, 235-253.

Henderson, D. A. (1999). The looming threat of bioterrorism. Science, 282, 1279-1282.

Kennedy, D. M. (Ed.). (2007). The Library of Congress World War II companion (p. 404). New York, NY: Simon & Schuster.

Khardori, N. (Ed.). (2006). Bioterrorism preparedness: Medicine – Public health – Policy. Weinheim, DE: Wiley-VCH.

Kracalik, I., Malania, L., Tsertsvadze, N., Manvelyan, J., Bakanidze, L., Imnadze, P., … Blackburn, J. K. (2014). Human cutaneous anthrax, Georgia, 2010-2012. Emerging Infectious Diseases, 20(2), 261-264. doi: 10.3201/eid2002.130522

Kuehnert, M. J., Doyle, T. J., Hill, H. A., Bridges, C. B., Jernigan, J. A., … Jernigan, D. B. (2003). Clinical features that discriminate inhalational anthrax from other acute respiratory illnesses. Clinical Infectious Disease, 36, 328-336.

Lawhorn, D. B. (2002). Bioterrorism preparedness – Anthrax. Retrieved from http:// agrilifecdn.tamu.edu/victoriacountyagnr/ files/2010/07/Bioterrorism-Preparedness- Anthrax.pdf

Malecki, J., Wiersma, S., Labinson, R., Kamel, L., Besnitz, E., DiFerdinando, G., … Stroube, R. (2001). Update: Investigation of bioterrorism- related anthrax and adverse events from antimicrobial prophylaxis. Morbidity and Mortality Weekly Report, 50(44), 973-976. Retrieved from http:// www.cdc.gov/mmwr/preview/mmwrhtml/ mm5044a1.htm

Mazumdar, S. (2009). Raxibacumab. mAbs, 1(6), 531-538.

Merrill, R., & Timmreck, T. (2006). Introduction to epidemiology (4th ed.). Sudbury, MA: Jones & Bartlett.

Mitka, M. (2012). Anthrax detection. Journal of the American Medical Association, 308(18), 1849. doi:10.1001/jama.2012.14658.

National Institutes of Health, National Institute of Allergy and Infectious Diseases. (2015). Biodefense and emerging infectious diseases. Retrieved from http://www.niaid.nih. gov/topics/biodefenserelated/biodefense/ pages/default.aspx

New York State Department of Health. (1999). Basis statistics: About incidence, prevalence, morbidity, and mortality – Statistics teaching tools. Retrieved from https://www. health.ny.gov/diseases/chronic/basicstat.htm

Nobelprize.org. (2014). Robert Koch – Biographical. Retrieved from http://www.nobel prize.org/nobel_prizes/medicine/laureates/ 1905/koch-bio.html

Piehler, J. K. (Ed.) (2013). Encyclopedia of military science. Los Angeles, CA: Sage.

Primack, J. R., & von Hippel, F. (1974). Advice and dissent: Scientists in the political arena. New York, NY: Basic Books.

Rogers, P., Whitby, S., & Dando, M. (1999). Biological warfare against crops. Scientific American, June, 70-75.

Scanes, C. G., & Miranowski, J. A. (2004). Perspectives in world food and agriculture 2004, volume 1. Ames, IA: Iowa State Press.

Schneeman, A., & Manchester, M. (2009). Antitoxin antibodies in prophylaxis and treatment of inhalation anthrax. Future Microbiology, 4, 35-43.

Sprenkle, M. D., Griffith, J., Marinelli, W., Boyer, A. E., Quinn, C. P., Pesik, N. T., … Blaney, D. D. (2014). Lethal factor and anti-protective antigen IgG levels associated with inhalation anthrax, Minnesota, USA. Emerging Infectious Diseases, 20(2), 310-314.

Stern, E. J., Uhde, K. B., Shadomy, S. V., & Messonnier, N. (2008). Conference report on public health and clinical guideline for anthrax. Emerging Infectious Diseases, 14(4), e1. doi: 10.3201/eid1404.070969

Stewart, P. (2015). U.S. army chief says no human error seen in anthrax mishap. Retrieved from http://www.reuters.com/ article/us-usa-miltary-anthrax-idUSKBN0O C2KU20150528

Swartz, M. N. (2001). Recognition and management of anthrax – An update. New England Journal of Medicine, 345(22), 1621-1626.

Takahashi, H., Keim, P., Kaufmann, A. F., Keys, C., Smith, K. L., Taniguchi, K., … Kurata, T. (2004). Bacillus anthracis bioterrorism incident, Kameido, Tokyo, 1993. Emerging Infectious Diseases, 10(1). Retrieved from http://wwwnc.cdc.gov/eid/ article/10/1/03-0238_article

U.S. Department of Health and Human Services. (2013). News: HHS replenishes nation’s supply of anthrax antitoxin. Retrieved from http://www.hhs.gov/news/press/2013pres/ 09/20130919a.html

U.S. Department of Justice. (2010). Amerithrax investigation summary. Retrieved from http://www.justice.gov/archive/amerithrax/ docs/amx-investigative-summary.pdf

U.S. Department of State, Archive. (n.d.). Foreign relations, 1969-1976, Volume E-2, documents on arms control, 1969- 1972: [461] Nov. 25 public papers of the presidents: 461 statement on chemical and biological defense policies and programs. November 25, 1969. Retrieved from http://2001-2009.state.gov/r/pa/ho/frus/ nixon/e2/83597.htm

U.S. Food and Drug Administration. (2012). FDA news release: FDA approves raxibacumab to treat inhalational anthrax. Retrieved from http://www.fda.gov/NewsEvents/Newsroom/ PressAnnouncements/ucm332341.htm

Vladan, R., Goran, B., & Larisa, J. (2012). A mathematical model of bioterrorist attack risk assessment. Journal of Bioterrorism and Biodefense, 2, 114. doi:10.4172/2157- 2526.1000114

Wheelis, M. (2002). Biological warfare at the 1346 siege of Caffa. Emerging Infectious Diseases, 8(9).

World Health Organization. (2008). Anthrax in humans and animals (4th ed.). Retrieved from http://www.who.int/csr/resources/ publications/anthrax_web.pdf

Yassin, N. A., & Ahmad, A. M. (2012). Incidence and resistotyping of Bacillus subtilis isolated from Azadi Teaching Hospital in Duhok City, Iraq. Materia Sociomedica, 24(3) 194-197.